What is the average lifespan of a liver transplant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The average lifespan of a liver transplant is approximately 20-30 years, with survival rates of 96% at 1 year and 71% at 10 years after transplantation, as reported in the most recent and highest quality study 1. The longevity of a liver transplant is influenced by several factors, including the recipient's age and overall health, the quality of the donor organ, adherence to immunosuppressive medication regimens, and the development of complications.

  • Recipient's age: The study found that elderly candidates, including those over 65 and 70 years, have comparable patient mortality and graft loss rates to younger recipients, with a 20-30% loss of potential life span beyond the first year after transplantation 1.
  • Donor organ quality: The quality of the donor organ plays a crucial role in determining the longevity of the transplant, with factors such as the donor's age, medical history, and organ condition affecting the outcome.
  • Adherence to immunosuppressive medication: Patients must take lifelong immunosuppressant medications, such as tacrolimus, cyclosporine, or sirolimus, to prevent rejection, along with regular monitoring of liver function.
  • Complications: The first year after transplantation is the most critical period, with the highest risk of complications, including rejection, infection, and technical issues. Lifestyle factors, such as avoiding alcohol, maintaining a healthy weight, and managing conditions like diabetes and hypertension, can significantly extend the life of a transplanted liver. With advances in surgical techniques, organ preservation methods, and immunosuppressive therapies, transplant outcomes continue to improve over time, as reported in the study 1.

From the Research

Liver Transplant Longevity

The average lifespan of a liver transplant can vary depending on several factors, including the recipient's overall health, the quality of care, and the presence of any complications.

  • According to a study published in 2022 2, liver transplant recipients who survive for more than 10 years can have a relatively normal life expectancy, with 211 out of 215 recipients remaining alive with normal liver function.
  • Another study from 2007 3 found that the five-year survival rate of patients alive 15 years after transplantation was 78%, with a median follow-up of 18.8 years after transplantation.

Factors Affecting Longevity

Several factors can affect the longevity of a liver transplant, including:

  • The type of immunosuppression used, with tacrolimus-based immunosuppression being associated with a higher risk of de novo malignancy 4
  • The presence of comorbidities, such as hypertension, diabetes, and osteoporosis, which can increase the risk of complications and reduce life expectancy 3, 5
  • The recipient's age, with younger recipients tend to have better outcomes and longer life expectancy 6

Quality of Life

Liver transplant recipients can have a good quality of life, with many being able to return to normal activities and achieve important socioeconomic milestones.

  • A study from 2010 6 found that 20-year survivors of liver transplantation had lower physical scores but comparable mental scores on the SF-36 survey compared to the general population.
  • Another study from 2007 3 found that patients who survived for more than 15 years after liver transplantation had a satisfactory quality of life, with a median score of 7 on a scale of 0 to 10.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Liver Transplant Recipients Who Survive for More Than 10 Years: A Long-Term Survey.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2022

Research

Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.

Transplant international : official journal of the European Society for Organ Transplantation, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.